Drug Description in Trials / DrugBank / KEGG DRUG


Search results


No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1TAMOXIFEN
(D08559)
[1] Tamoxifen[1] Tamoxifen (D08559) 💬[2] ESR1,
ESR2 💬
[10] Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬[3] 2, 113, 227 💬
2Tamoxifen 20mg Hexal® Filmtabletten
(D08559)
[1] Tamoxifen[1] Tamoxifen (D08559) 💬[2] ESR1,
ESR2 💬
[10] Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬[1] 113 💬
3Tamoxifen 40 mg daily for one year
(D08559)
[1] Tamoxifen[1] Tamoxifen (D08559) 💬[2] ESR1,
ESR2 💬
[10] Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬[1] 2 💬
4TAMOXIFEN CITRATE
(D08559)
[1] Tamoxifen[1] Tamoxifen (D08559) 💬[2] ESR1,
ESR2 💬
[10] Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬[1] 113 💬